Not applicableUnknownNCT03865875What this trial is testingPilot Study of a Multimodal Prehabilitation Pancreatic Cancer ProgramWho this might be right forPancreatic Ductal Adenocarcinoma Massachusetts General Hospital 40
Not applicableLooking for participantsNCT00912717What this trial is testingPancreatic Adenocarcinoma Gene Environment Risk StudyWho this might be right forPancreatic Cancer University of Pittsburgh 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT05379985What this trial is testingStudy of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASWho this might be right forNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more Revolution Medicines, Inc. 754
Early research (Phase 1)Study completedNCT00622674What this trial is testingBortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+5 more Masonic Cancer Center, University of Minnesota 37
Not applicableStudy completedNCT00489515What this trial is testingVisceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or GallbladderWho this might be right forColorectal CancerGallbladder CancerGastric Cancer+2 more Wake Forest University Health Sciences 115
Testing effectiveness (Phase 2)Study completedNCT00052689What this trial is testingBortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic CancerWho this might be right forDuct Cell Adenocarcinoma of the PancreasStage IV Pancreatic Cancer National Cancer Institute (NCI) 88
Early research (Phase 1)Study completedNCT01204476What this trial is testingCixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaWho this might be right forGastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05604560What this trial is testingA Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas CancerWho this might be right forPancreatic Cancer Lei Zheng 25
Not applicableUnknownNCT04115527What this trial is testingShould a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.Who this might be right forPancreatic Ductal Adenocarcinoma Ruijin Hospital 100
Not applicableUnknownNCT03500068What this trial is testingEstablishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.Who this might be right forCarcinoma, Pancreatic Ductal Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Not applicableStudy completedNCT01846520What this trial is testingFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersWho this might be right forHealthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more City of Hope Medical Center 200
Not applicableStudy completedNCT01989624What this trial is testingPAncreatic Adenocarcinoma in HospitalWho this might be right forPancreatic Adenocarcinoma Centre Hospitalier Departemental Vendee 1,204
Early research (Phase 1)WithdrawnNCT02831179What this trial is testingVeliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWho this might be right forFunctional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more Vanderbilt-Ingram Cancer Center
Not applicableStudy completedNCT04128332What this trial is testingPre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic CancerWho this might be right forCancer of Pancreas CCTU- Cancer Theme 10
Testing effectiveness (Phase 2)Looking for participantsNCT03492671What this trial is testingTesting the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic CancerWho this might be right forPancreas AdenocarcinomaResectable Pancreatic Cancer Loma Linda University 30
Large-scale testing (Phase 3)UnknownNCT04617821What this trial is testingAG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic CancerWho this might be right forBorderline Resectable Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma Fudan University 300
Not applicableWithdrawnNCT01911416What this trial is testingA Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic CancerWho this might be right forPancreatic Ductal Adenocarcinoma University of Utah
Testing effectiveness (Phase 2)Looking for participantsNCT07670312What this trial is testingEvaluation of XYA02 in Patients With Advanced Solid TumorsWho this might be right forMUC1-expressing Advanced, Relapsed and/or Refractory Solid TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more XYone Therapeutics, Inc 190
Not applicableUnknownNCT04245644What this trial is testingEfficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS StudyWho this might be right forDisease Free SurvivalOverall SurvivalPancreatic Cancer Massimo Falconi 800
Testing effectiveness (Phase 2)Study completedNCT03611556What this trial is testingMEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.Who this might be right forCarcinomaMetastatic Pancreatic Adenocarcinoma MedImmune LLC 213